<i>PROL1</i> is essential for xenograft tumor development in mice injected with the human prostate cancer cell-line, LNCaP, and modulates cell migration and invasion.

Publication Year: 2021

DOI:
10.31083/jomh.2021.131

PMCID:
PMC9089447

PMID:
35547856

Journal Information

Full Title: J Mens Health

Abbreviation: J Mens Health

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public, Environmental & Occupational Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: The author declares no conflict of interest."

Evidence found in paper:

"Funding This research was funded by NIH/NIDDK, grant number DK107807 and DK109314 (PI: Kelvin P. Davies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025